Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Otsuka Pharmaceutical Co Ltd
Otsuka Pharmaceutical Factory Inc
Original Assignee
Otsuka Pharmaceutical Co Ltd
Otsuka Pharmaceutical Factory Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Otsuka Pharmaceutical Co Ltd, Otsuka Pharmaceutical Factory IncfiledCriticalOtsuka Pharmaceutical Co Ltd
Priority to JP59101588ApriorityCriticalpatent/JPS60246365A/ja
Priority to US06/703,365prioritypatent/US4642355A/en
Priority to GB08504430Aprioritypatent/GB2158444B/en
Priority to DE19853506307prioritypatent/DE3506307A1/de
Priority to CH838/85Aprioritypatent/CH664956A5/de
Priority to FR858502661Aprioritypatent/FR2560195B1/fr
Priority to IT05120/85Aprioritypatent/IT1203608B/it
Publication of JPS60246365ApublicationCriticalpatent/JPS60246365A/ja
Publication of JPH0512360B2publicationCriticalpatent/JPH0512360B2/ja
processo para a sìntese de um estereoisÈmero substancialmente puro, compostos, composição farmacêutica que compreende um composto, processo para a sìntese de um composto e uso do mesmo.
Устойчиви соли на (+)-(1s,2r)-2-//n-(2-хидроксиламино-2- оксоетил)-n-метил-амино/карбонил/циклохексан-1-карбонова киселина, метод за получаването им и фармацевтични състави, в които те се съдържат